Why the study?
Does pretreatment with candesartan improve left ventricular function and remodeling during acute myocardial infarction in Sprague-Dawley rats?
Population
Sprague-Dawley rats with acute myocardial infarction
Comparison
Candesartan (10 mg/kg/d) for 2 weeks prior to MI vs Untreated rats
Design
Preclinical
Follow-up
1, 3, and 6 minutes after MI
Authors
Loading...
Should not change clinical practice; hypothesis-generating for candesartan pretreatment in experimental MI.
Does pretreatment with candesartan improve left ventricular function and remodeling during acute myocardial infarction in Sprague-Dawley rats?
Pretreatment with candesartan before acute MI improves global LV function and attenuates LV remodeling in a rat model.
Thai et al. (2006) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: